ES458819A1 - Pharmaceutical preparations for venotonic use - Google Patents

Pharmaceutical preparations for venotonic use

Info

Publication number
ES458819A1
ES458819A1 ES458819A ES458819A ES458819A1 ES 458819 A1 ES458819 A1 ES 458819A1 ES 458819 A ES458819 A ES 458819A ES 458819 A ES458819 A ES 458819A ES 458819 A1 ES458819 A1 ES 458819A1
Authority
ES
Spain
Prior art keywords
venotonic
pharmaceutical preparations
isopropyl
butyl
ethylefin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES458819A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES458819A1 publication Critical patent/ES458819A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02Ergot alkaloids of the cyclic peptide type
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Procedure for the preparation of a pharmaceutical composition comprising a mixture of ethylefin and a hydrogenated alkaloid ergot, of formula I in which R is hydrogen or alkyl containing 1 to 4 carbon atoms, excluding butyl trec., R1 is methyl, ethyl or isopropyl, R2 is isopropyl, butyl sec., isobutyl or benzyl, *** See image (Machine-translation by Google Translate, not legally binding)
ES458819A 1976-05-17 1977-05-16 Pharmaceutical preparations for venotonic use Expired ES458819A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762621906 DE2621906A1 (en) 1976-05-17 1976-05-17 NEW THERAPEUTIC MIXTURE AND METHOD FOR PRODUCING IT

Publications (1)

Publication Number Publication Date
ES458819A1 true ES458819A1 (en) 1978-08-01

Family

ID=5978199

Family Applications (1)

Application Number Title Priority Date Filing Date
ES458819A Expired ES458819A1 (en) 1976-05-17 1977-05-16 Pharmaceutical preparations for venotonic use

Country Status (22)

Country Link
JP (1) JPS52139730A (en)
AT (1) AT366574B (en)
AU (1) AU513718B2 (en)
BE (1) BE854694A (en)
CA (1) CA1088865A (en)
CS (1) CS207455B2 (en)
DE (1) DE2621906A1 (en)
ES (1) ES458819A1 (en)
FR (1) FR2351657A1 (en)
GB (1) GB1565447A (en)
GR (1) GR72995B (en)
HK (1) HK3283A (en)
HU (1) HU175167B (en)
IE (1) IE45197B1 (en)
IL (1) IL52101A (en)
MY (1) MY8400062A (en)
NL (1) NL177981C (en)
NZ (1) NZ184111A (en)
PH (1) PH20257A (en)
PT (1) PT66552B (en)
SE (1) SE425545B (en)
ZA (1) ZA772935B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2935515A1 (en) * 1979-09-03 1981-03-19 Fa. Dr. Willmar Schwabe, 7500 Karlsruhe MEDICINAL PRODUCT
JPH0227013U (en) * 1988-08-10 1990-02-22
MXPA01009658A (en) 1999-03-26 2003-06-24 Pozen Inc High potency dihydroergotamine compositions.

Also Published As

Publication number Publication date
JPS628413B2 (en) 1987-02-23
SE7705340L (en) 1977-11-18
GR72995B (en) 1984-01-24
IE45197L (en) 1977-11-17
PT66552A (en) 1977-06-01
CA1088865A (en) 1980-11-04
ATA347677A (en) 1981-09-15
GB1565447A (en) 1980-04-23
HU175167B (en) 1980-05-28
DE2621906A1 (en) 1977-12-01
HK3283A (en) 1983-01-20
AU2516977A (en) 1978-11-23
NL177981C (en) 1986-01-02
IL52101A (en) 1980-01-31
BE854694A (en) 1977-11-16
CS207455B2 (en) 1981-07-31
IL52101A0 (en) 1977-07-31
NL7705306A (en) 1977-11-21
MY8400062A (en) 1984-12-31
AU513718B2 (en) 1980-12-18
NZ184111A (en) 1980-02-21
NL177981B (en) 1985-08-01
PH20257A (en) 1986-11-14
SE425545B (en) 1982-10-11
AT366574B (en) 1982-04-26
ZA772935B (en) 1979-01-31
IE45197B1 (en) 1982-07-14
FR2351657B1 (en) 1980-01-18
JPS52139730A (en) 1977-11-21
FR2351657A1 (en) 1977-12-16
PT66552B (en) 1979-09-03
DE2621906C2 (en) 1988-04-21

Similar Documents

Publication Publication Date Title
ES459024A1 (en) Tetracyclic derivatives and pharmaceutical compositions of matter
ES456287A1 (en) Polyoxygenated labdane derivatives
IT1065978B (en) ADHESIVE COMPOSITION CONTAINING GELIFYING AGENTS
ES457050A1 (en) Cyclic sulphonyloxyimides
SE7409574L (en)
ES447509A1 (en) Spacer-damper
ES8503667A1 (en) 2-Oxo-imidazolidine compounds, a process for preparing the same and a pharmaceutical composition.
ES8800142A1 (en) Semicarbazide derivatives, processes for preparation thereof and pharmaceutical composition comprising the same.
ES458819A1 (en) Pharmaceutical preparations for venotonic use
ES8106289A1 (en) Derivatives of alpha-phenyl-2-pyrrolidine methanol and their salts, process for their preparation, use as medicines and compositions containing them.
ES462662A1 (en) Derivatives of 2-(3-phenyl-2-aminopropionyloxy)-acetic acid
GB2000165A (en) Process for the addition of silicon-bonded hydrogen atoms to aliphatic multiple-bonds curable compositions and their use
ES462304A1 (en) Substituted 4-phenylurazoles and their use in agricultural fungicide compositions
IE781598L (en) Stable solutions of hydrogenated ergopeptide alkaloids
ES468630A1 (en) Isoquinoline derivatives and pharmaceutical compositions containing them
ES451466A1 (en) 5-thiazole-methane-amines, and their use as antilipolytics
ES435955A1 (en) A procedure for obtaining a pirid derivative (3,4-d) pyridezine. (Machine-translation by Google Translate, not legally binding)
ES475596A1 (en) Phenoxyalkanolamine derivatives
ES465929A1 (en) 2 - phenyl - picyclic - 1,2,4 - triazoles and their use as herbicides
DE2862069D1 (en) Heterocyclic norbornane derivatives, plant-growth regulating compositions containing these compounds and process for the preparation of these compositions
ES438704A1 (en) Ergot peptide alkaloids
SE7708452L (en) COMPOSITION CONTAINING AN ANTHRAKINON COMPOUND
ES8702392A1 (en) Thiadiazinone compounds, process for their preparation, and pharmaceutical compositions containing them.
ES8505665A1 (en) Acylaminophenol derivatives
ES467791A1 (en) 1-Phenyl-2-amino-1,3-propanediol-N-aryloxyalkyl derivatives